Jorge A. Carrasquillo

National Institutes of Health — United States

Medicine · Health Sciences

73h-index16.3kcitations432works3.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Radiopharmaceutical Chemistry and Applications(198), Monoclonal and Polyclonal Antibodies Research(125), Medical Imaging Techniques and Applications(65), Adrenal and Paraganglionic Tumors(53), Medical Imaging and Pathology Studies(50)

Publications430 total

Correction: Case series: ATRX variants in four patients with metastatic pheochromocytoma
Frontiers in Endocrinology·2025Open Access
Erratum: Phase II Study of <sup>177</sup> Lu-DOTATATE for Progressive Metastatic Pheochromocytomas and Paragangliomas: Interim Analysis of Efficacy, Safety, and Biomarkers
Journal of Clinical Oncology·2025· 1 cited
Phase II Study of <sup>177</sup> Lu-DOTATATE for Progressive Metastatic Pheochromocytomas and Paragangliomas: Interim Analysis of Efficacy, Safety, and Biomarkers
Journal of Clinical Oncology·2025· 3 citedOpen Access
Development and validation of pan-cancer lesion segmentation AI-model for whole-body 18F-FDG PET/CT in diverse clinical cohorts
Computers in Biology and Medicine·2025· 1 cited
Effect of absorbed dose on toxicity and tumor response of Lu-177-DOTATATE with olaparib in gastroenteropancreatic neuroendocrine patients: preliminary results
Endocrine Abstracts·2025
DNA damage repair mutational status's effect on Lu-177-DOTATATE in combination with olaparib in metastatic SSTR+ GI neuroendocrine tumor: preliminary results
Endocrine Abstracts·2025
Phase 1 dose-escalation trial using convection-enhanced delivery of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma
Neuro-Oncology·2025· 9 citedOpen Access
Whole-body PET imaging of simian immunodeficiency virus using gp120-targeting probes fails to reveal regions of specific uptake in rhesus macaques
European Journal of Nuclear Medicine and Molecular Imaging·2025· 2 citedOpen Access
An automated pheochromocytoma and paraganglioma lesion segmentation AI-model at whole-body 68Ga- DOTATATE PET/CT
EJNMMI Research·2024· 4 citedOpen Access
Case Series: ATRX Variants in Four Patients with Metastatic Pheochromocytoma
Frontiers in Endocrinology·2024· 1 citedOpen Access
Whole-body PET imaging of SIV using anti-Env probes fails to reveal regions of specific uptake in rhesus macaques
2024· 1 citedOpen Access
Diagnostic performance of [68Ga]DOTATATE PET/CT, [18F]FDG PET/CT, MRI of the spine, and whole-body diagnostic CT and MRI in the detection of spinal bone metastases associated with pheochromocytoma and paraganglioma
European Radiology·2024· 16 citedOpen Access
Phase 1 trial of Pb-212-VMT-alpha-NET in select metastatic or inoperable somatostatin receptor positive tumors
Endocrine Abstracts·2023· 1 cited
Ratio of total uptake volume on DOTATATE vs FDG PET as a predictive marker of treatment efficacy of Lu-177-DOTATATE in metastatic pheochromocytoma
Endocrine Abstracts·2023
Phase 1/2 trial of Pb-212-VMT-alpha-NET in GI neuroendocrine tumors and pheochromocytoma/paraganglioma previously treated with radioligand therapy
Endocrine Abstracts·2023
Phase 2 trial of lu-177-DOTATATE in metastatic or inoperable pheochromocytoma/paraganglioma: interim analysis results
Endocrine Abstracts·2023· 4 cited
Phase 1/2 study of Lu-177-DOTATATE in combination with olaparib in metastatic or inoperable GI neuroendocrine tumors - first results
Endocrine Abstracts·2023· 1 cited
Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement
Nature Reviews Endocrinology·2023· 74 citedOpen Access
Early short-term effects on catecholamine levels and pituitary function in patients with pheochromocytoma or paraganglioma treated with [177Lu]Lu-DOTA-TATE therapy
Frontiers in Endocrinology·2023· 10 citedOpen Access
Figure S2 from &lt;i&gt;EGFR&lt;/i&gt; and &lt;i&gt;MET&lt;/i&gt; Amplifications Determine Response to HER2 Inhibition in &lt;i&gt;ERBB2&lt;/i&gt;-Amplified Esophagogastric Cancer
2023Open Access
page 1 of 22Next →

Frequent Co-authors

Steven M. Larson(20), Millie Whatley(10), Neeta Pandit‐Taskar(10), Clara C. Chen(9), Jason S. Lewis(9), Serge K. Lyashchenko(8), Alexander Ling(7), Joseph A. O’Donoghue(7), Graeme Eisenhofer(6), Karel Pacák(6), Wolfgang Weber(6), Karen T. Adams(5), Howard I. Scher(5), Michael J. Morris(5), Henri Timmers(4), Karel Pacák(4), Pat Zanzonico(4), Stephen B. Solomon(4), James C. Reynolds(4), Shutian Ruan(4)